Magnolia supplement for psoriasis immune health
Part of Skin clinical trials.
This trial tests whether a magnolia dietary supplement can improve immune markers in people with psoriasis. If you have stable psoriasis (for at least 6 months) and are not using certain strong medications, you may be able to participate from home by using a smartphone app and mailing blood samples.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have had psoriasis for at least 6 months, diagnosed by a skin doctor.
- You have not used certain strong psoriasis medications (like methotrexate, cyclosporine, or biologics like Humira) in the last few months.
- You have a smartphone (iPhone or Android) and can use an app called Chloe by People Science.
- You live in the United States and can receive shipments and mail blood samples.
- You are not pregnant, planning pregnancy, or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new oral medication for psoriasis in healthy volunteers to check its safety and how the body handles it. It is an early-phase trial to gather information before testing in patients.
This trial tests a new medication, CBP-0276, to see if it improves psoriasis symptoms and quality of life. It is for people with moderate to severe plaque psoriasis who might need stronger treatment.
This trial studies how guselkumab works for people with long-lasting, more severe psoriasis and signs that may affect joints. It may help by improving psoriasis symptoms and possibly reducing related inflammation, while researchers track safety and outcomes.
This study tests whether adding a Mediterranean diet to your psoriasis treatment can improve your skin. You will be asked to follow a heart-healthy diet for several months while taking a new biologic medicine.
This study looks at what’s happening inside the body in people with plaque psoriasis who start certain biologic medicines that target the IL-23/IL-17 immune pathway. It may help explain why these treatments work and what body changes are linked to response.
This trial tests an experimental pill that may help clear psoriasis plaques. It is for people whose current topical treatments (creams or ointments) are not working well enough or cause side effects.
Hear when a new Psoriasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.